
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE:ZTS) is a pharma company “without all the problems that come with traditional pharmaceutical companies,” like generic competition and dealing with Medicare or insurance.
Joshua Brown of Ritholtz Wealth Management stated that ChargePoint Holdings Inc (NYSE:CHPT) “increasingly looks like it bottomed in early May.” He added that the stock is “very resilient.”